Human trials for Chinese mRNA vaccine set to begin in China
The phase I clinical trial of the COVID-19 mRNA vaccine developed by a Shanghai-based biotechnology firm has completed patient enrollment in China, according to a report by online news portal ThePaper.cn.
Shen Haifa Zhongshan Hospital Affiliated To Fudan University Stemirna Therapeutics Zhongshan Hospital Affiliated Fudan University Covid 19
Source: chinadaily.com.cn